Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Lung Neoplasms × Thoracoscopy × Clear all

Phase

Status

Completed 2 Withdrawn 1 Unknown 1 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 40 Radiotherapy 31 Pemetrexed 28 Docetaxel 27 Cisplatin 27 Paclitaxel 20 Gemcitabine 18 Nivolumab 16 Etoposide 14 Radiosurgery 12 pembrolizumab 11 Erlotinib Hydrochloride 11 Magnetic Resonance Spectroscopy 10 Radiation 9 Bevacizumab 9 Vinorelbine 7 Cyclophosphamide 6 durvalumab 5 Immunoglobulin G 5 Gefitinib 5 Drug Therapy 5 Disulfides 5 Dexamethasone 5 Chemotherapy, Adjuvant 5 Celecoxib 5 bintrafusp alfa protein, human 4 atezolizumab 4 Specimen Handling 4 Metformin 4 Irinotecan 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03272087 2020-12-17

REPEAT

Naestved Hospital

Phase NA Terminated

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡